On 26 October, the FEAM European Biomedical Policy Forum, with the support of AstraZeneca and the European Infrastructure for Translational Medicine (EATRIS), will hold its Annual Lecture on ‘Digital Health and AI: Benefits and Costs of Data Sharing in the EU’.

Professor Luis Marti-Bonmati, FEAM Board Member and AI expert lead will be one of the participants in this discussion about the Benefits and Costs of Data Sharing in the EU.

In this interview, he speaks about the pros and cons of AI in medicine and addresses whether Europe is ready for the digital transition.

Find out more about this event here: [ Ссылка ]
.
.
.
.
.
Credits music: [ Ссылка ]

свернуть